Background:
The thyroid imaging reporting and data system (TI-RADS), classified and determined the risk of thyroid nodule malignancy with ultrasound scanning. Contrast-enhanced ultrasound (CEUS) is newly developed methods which could measure perfusion features.
Objective:
The aim of the study was to investigate the value of diagnosing thyroid nodules using TI-RADS combined with CEUS and determine whether improvements were made to the diagnostic accuracy.
Methods:
The features of conventional ultrasonography (US) and CEUS ion 117 case of thyroid nodules samples, which were confirmed by fine-needle aspiration and/or surgery, were retrospectively analyzed. The independent US and CEUS predictors for malignancy were determined and quantified using logistic regression analysis. The receiver operating characteristic (ROC) curve analysis was used to compare the diagnostic efficiency of each method in predicting malignant solid thyroid nodules.
Results:
The TI-RADS + CEUS combination had the highest accuracy (94.02%), sensitivity (94.74%), specificity (93.33%), PPV (93.10%) and NPV (94.92%), significantly greater than that of TI-RADS alone and CEUS alone (χ2 = 8.746, P < 0.001; χ2 = 9.825, P < 0.001). The area under the ROC curve (AUC) of TI-RADS alone, CEUS alone, and combined use of TI-RADS and CEUS were 0.871, 0.884, and 0.942, respectively. The following conventional US and CEUS features based on logistic regression analysis showed significant predictive value for thyroid malignant nodules: Obscure margin, calcification, hypoechoic, low enhancement, rim-like enhancement.
Conclusions:
TI-RADS in combination with CEUS has superior diagnostic efficiency in the discrimination of benign and malignant thyroid lesions, compared with TI-RADS and CEUS alone.
Citing Articles
Integrated use of contrast-enhanced and grey-scale ultrasound in assigning American College of Radiology Thyroid Imaging-Reporting and Data System scores for characterisation of thyroid nodules: A prospective observational study.
Verma A, Krishna K A, Kumar I, Singh P, Kar A, Agrawal N
Ultrasound. 2024; 32(3):140-149.
PMID: 39100794
PMC: 11292930.
DOI: 10.1177/1742271X231225056.
Diagnostic value of qualitative and quantitative parameters of contrast-enhanced ultrasound for differentiating differentiated thyroid carcinomas from benign nodules.
Fan J, Tao L, Zhan W, Li W, Kuang L, Zhao Y
Front Endocrinol (Lausanne). 2024; 14:1240615.
PMID: 38250738
PMC: 10797774.
DOI: 10.3389/fendo.2023.1240615.
Contrast Enhancement Ultrasound Improves Diagnostic Accuracy for Thyroid Nodules: A Prospective Multicenter Study.
Li J, Dou J, Li H, Xiao F, Yu J, Xie M
J Endocr Soc. 2023; 8(1):bvad145.
PMID: 38075563
PMC: 10699741.
DOI: 10.1210/jendso/bvad145.
A machine learning-based sonomics for prediction of thyroid nodule malignancies.
Arabi M, Nazari M, Salahshour A, Jenabi E, Hajianfar G, Khateri M
Endocrine. 2023; 82(2):326-334.
PMID: 37291392
DOI: 10.1007/s12020-023-03407-6.
The use of modified TI-RADS using contrast-enhanced ultrasound features for classification purposes in the differential diagnosis of benign and malignant thyroid nodules: A prospective and multi-center study.
Zhou P, Chen F, Zhou P, Xu L, Wang L, Wang Z
Front Endocrinol (Lausanne). 2023; 14:1080908.
PMID: 36817602
PMC: 9929352.
DOI: 10.3389/fendo.2023.1080908.
The diagnostic value of a nomogram based on multimodal ultrasonography for thyroid-nodule differentiation: A multicenter study.
Yi D, Fan L, Zhu J, Yao J, Peng C, Xu D
Front Oncol. 2022; 12:970758.
PMID: 36059607
PMC: 9435436.
DOI: 10.3389/fonc.2022.970758.
Differentiation of Thyroid Nodules (C-TIRADS 4) by Combining Contrast-Enhanced Ultrasound Diagnosis Model With Chinese Thyroid Imaging Reporting and Data System.
Zhu T, Chen J, Zhou Z, Ma X, Huang Y
Front Oncol. 2022; 12:840819.
PMID: 35847847
PMC: 9280912.
DOI: 10.3389/fonc.2022.840819.
Systematic review and meta-analysis: diagnostic value of different ultrasound for benign and malignant thyroid nodules.
Wu Y, Zhou C, Shi B, Zeng Z, Wu X, Liu J
Gland Surg. 2022; 11(6):1067-1077.
PMID: 35800749
PMC: 9253179.
DOI: 10.21037/gs-22-254.
Clinical Application of C-TIRADS Category and Contrast-Enhanced Ultrasound in Differential Diagnosis of Solid Thyroid Nodules Measuring ≥1 cm.
Jin Z, Zhu Y, Lei Y, Yu X, Jiang N, Gao Y
Med Sci Monit. 2022; 28:e936368.
PMID: 35668611
PMC: 9188288.
DOI: 10.12659/MSM.936368.
Performance of Contrast-Enhanced Ultrasound in Thyroid Nodules: Review of Current State and Future Perspectives.
Radzina M, Ratniece M, Putrins D, Saule L, Cantisani V
Cancers (Basel). 2021; 13(21).
PMID: 34771632
PMC: 8582579.
DOI: 10.3390/cancers13215469.
Independent risk factors and feasibility of ultrasound diagnosis of ultrasound-guided non-cytologically diagnostic thyroid nodules.
Jiang C, Chang J, Chen X, Zhang H, Xu M
Gland Surg. 2021; 10(9):2724-2733.
PMID: 34733722
PMC: 8514318.
DOI: 10.21037/gs-21-512.
High-performance sonographical multimodal imaging of non cystic thyroid lesions: Chances of the preoperative diagnostics in relation to histopathology.
Brandenstein M, Wiesinger I, Jung F, Stroszczynski C, Jung E
Clin Hemorheol Microcirc. 2021; 79(1):27-38.
PMID: 34334387
PMC: 8609687.
DOI: 10.3233/CH-219101.
Contrast-Enhanced Ultrasound in the Differential Diagnosis and Risk Stratification of ACR TI-RADS Category 4 and 5 Thyroid Nodules With Non-Hypovascular.
Wang Y, Dong T, Nie F, Wang G, Liu T, Niu Q
Front Oncol. 2021; 11:662273.
PMID: 34123819
PMC: 8189148.
DOI: 10.3389/fonc.2021.662273.
Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules: An updated meta-analysis with comprehensive heterogeneity analysis.
Zhang J, Zhang X, Meng Y, Chen Y
PLoS One. 2020; 15(4):e0231775.
PMID: 32310968
PMC: 7170259.
DOI: 10.1371/journal.pone.0231775.